{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:04:19Z","timestamp":1774710259396,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,3]],"date-time":"2006-02-03T00:00:00Z","timestamp":1138924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mund Kiefer GesichtsChir"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s10006-005-0670-0","type":"journal-article","created":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T15:56:53Z","timestamp":1138895813000},"page":"73-81","source":"Crossref","is-referenced-by-count":49,"title":["Bisphosphonatassoziierte Osteonekrose des Kiefers","Bisphosphonate-associated osteonecrosis of the jaw"],"prefix":"10.1007","volume":"10","author":[{"given":"M. H.","family":"Abu-Id","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"A\u00e7il","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kreusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,3]]},"reference":[{"key":"670_CR1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","volume":"34","author":"Bagan","year":"2005","unstructured":"Bagan JV, Murillo J, Jimenez Y et al. (2005) Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 34: 120\u2013123","journal-title":"J Oral Pathol Med"},{"key":"670_CR1a","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos CA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonatly: incidence and risk factors. J Clin Oncol 23: 8580\u20138587","journal-title":"J Clin Oncol"},{"key":"670_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S8756-3282(01)00412-4","volume":"28","author":"Benford","year":"2001","unstructured":"Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ (2001) Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28: 465\u2013473","journal-title":"Bone"},{"key":"670_CR3","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","volume":"85","author":"Black","year":"2000","unstructured":"Black DM, Thompson DE, Bauer DC et al. (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85: 4118\u20134124","journal-title":"J Clin Endocrinol Metab"},{"key":"670_CR4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5694\/j.1326-5377.2005.tb06761.x","volume":"182","author":"Carter","year":"2005","unstructured":"Carter G, Goss AN, Doecke C (2005) Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 182: 413\u2013415","journal-title":"Med J Aust"},{"key":"670_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1834-7819.2003.tb00015.x","volume":"48","author":"Carter","year":"2003","unstructured":"Carter GD, Goss AN (2003) Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48: 268","journal-title":"Aust Dent J"},{"key":"670_CR6","first-page":"408","volume":"2","author":"Dearden","year":"1901","unstructured":"Dearden WF (1901) The causation of phosphorus necrosis. BMJ 2: 408","journal-title":"BMJ"},{"key":"670_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","volume":"296","author":"Dunford","year":"2001","unstructured":"Dunford JE, Thompson K, Coxon FP et al. (2001) Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296: 235\u2013242","journal-title":"J Pharmacol Exp Ther"},{"key":"670_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353: 99\u2013102","journal-title":"N Engl J Med"},{"key":"670_CR9","unstructured":"Eckert AW, Maurer P, Meyer L, Bilkenroth U, Schubert J (2005) Kieferchirurgische Komplikationen und Management bei Bisphosphonattherapie. Dtsch Zahn\u00e4rztl Z 60: A92"},{"key":"670_CR10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1200\/jco.2004.22.14_suppl.8088","volume":"22","author":"Estilo","year":"2004","unstructured":"Estilo CL, Poznak CH van, Williams T et al. (2004) Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: a retrospective study. J Clin Oncol 22: 747 (abstract)","journal-title":"J Clin Oncol"},{"key":"670_CR11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","volume":"32","author":"Ficarra","year":"2005","unstructured":"Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G (2005) Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32: 1123\u20131128","journal-title":"J Clin Periodontol"},{"key":"670_CR12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","volume":"19","author":"Fleisch","year":"1998","unstructured":"Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19: 80\u2013100","journal-title":"Endocr Rev"},{"key":"670_CR13","first-page":"6538","volume":"62","author":"Fournier","year":"2002","unstructured":"Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, Clezardin P (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62:6538\u20136544","journal-title":"Cancer Res"},{"key":"670_CR14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1034\/j.1600-0714.2000.291006.x","volume":"29","author":"Gonzalez-Moles","year":"2000","unstructured":"Gonzalez-Moles MA, Bagan-Sebastian JV (2000) Alendronate-related oral mucosa ulcerations. J Oral Pathol Med 29: 514\u2013518","journal-title":"J Oral Pathol Med"},{"key":"670_CR15","first-page":"52","volume":"3","author":"Gr","year":"2005","unstructured":"Gr\u00f6tz KA, Diel IJ (2005) Osteonekrose des Kiefers unter Bisphosphonat-Langzeittherapie. Im Focus Onkologie 3: 52\u201355","journal-title":"Im Focus Onkologie"},{"key":"670_CR16","first-page":"142","volume":"28","author":"Heiman","year":"1946","unstructured":"Heiman H (1946) Chronic phosphorus poisoning. J Ind Hyg Toxicol 28: 142\u2013150","journal-title":"J Ind Hyg Toxicol"},{"key":"670_CR17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","volume":"63","author":"Hellstein","year":"2005","unstructured":"Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63: 682\u2013689","journal-title":"J Oral Maxillofac Surg"},{"key":"670_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10006-005-0624-6","volume":"9","author":"Hoefert","year":"2005","unstructured":"Hoefert S, Eufinger H (2005) [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates]. Mund Kiefer GesichtsChir 9: 233\u2013238","journal-title":"Mund Kiefer GesichtsChir"},{"key":"670_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02547227","volume":"11","author":"Jung","year":"1973","unstructured":"Jung A, Bisaz S, Fleisch H (1973) The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res 11: 269\u2013280","journal-title":"Calcif Tissue Res"},{"key":"670_CR20","first-page":"36","volume":"7","author":"Kassowitz","year":"1884","unstructured":"Kassowitz M (1884) Die Behandlung der Rachitis mit Phosphor. Z Klin Med 7: 36\u201374","journal-title":"Z Klin Med"},{"key":"670_CR21","unstructured":"Krimmel M, Ferring I, Hoffmann J, G\u00fclicher D, Reinert S (2005) Klinischer Verlauf und Strategien in der Behandlung der Bisphosphonat-induzierten Osteonekrose der Kiefer. Dtsch Zahn\u00e4rztl Z 60: A93"},{"key":"670_CR22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1902\/jop.2005.76.7.1113","volume":"76","author":"Lane","year":"2005","unstructured":"Lane N, Armitage GC, Loomer P et al. (2005) Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. J Periodontol 76: 1113\u20131122","journal-title":"J Periodontol"},{"key":"670_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"Lin","year":"1996","unstructured":"Lin JH (1996) Bisphosphonates: a review of their pharmacokinetic properties. Bone 18: 75\u201385","journal-title":"Bone"},{"key":"670_CR24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjmed.2004.04.015","volume":"117","author":"Lugassy","year":"2004","unstructured":"Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O (2004) Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117: 440\u2013441","journal-title":"Am J Med"},{"key":"670_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"Maerevoet","year":"2005","unstructured":"Maerevoet M, Martin C, Duck L (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353: 99\u2013102","journal-title":"N Engl J Med"},{"key":"670_CR26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61: 1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"670_CR27","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"670_CR28","first-page":"111","volume":"71","author":"Melo","year":"2005","unstructured":"Melo MD, Obeid G (2005) Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 71: 111\u2013113","journal-title":"J Can Dent Assoc"},{"key":"670_CR29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1902\/jop.2005.76.11.1901","volume":"76","author":"Menezes","year":"2005","unstructured":"Menezes AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GA (2005) Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 76: 1901\u20131909","journal-title":"J Periodontol"},{"key":"670_CR30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-0714.2005.00351.x","volume":"34","author":"Merigo","year":"2005","unstructured":"Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P (2005) Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34: 613\u2013617","journal-title":"J Oral Pathol Med"},{"key":"670_CR31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","volume":"104","author":"Migliorati","year":"2005","unstructured":"Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104: 83\u201393","journal-title":"Cancer"},{"key":"670_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bdj.4802906","volume":"133","author":"Miles","year":"1972","unstructured":"Miles AE (1972) Phosphorus necrosis of the jaw: \u201ephossy jaw\u201c. Br Dent J 133: 203\u2013206","journal-title":"Br Dent J"},{"key":"670_CR33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1600-0773.1990.tb00750.x","volume":"66","author":"M","year":"1990","unstructured":"M\u00f6nkk\u00f6nen J, Koponen HM, Ylitalo P (1990) Comparison of the distribution of three bisphosphonates in mice. Pharmacol Toxicol 66: 294\u2013298","journal-title":"Pharmacol Toxicol"},{"key":"670_CR34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1034\/j.1600-0765.2001.036004244.x","volume":"36","author":"Myoung","year":"2001","unstructured":"Myoung H, Park JY, Choung PH (2001) Effects of a bisphosphonate on the expression of bone specific genes after autogenous free bone grafting in rats. J Periodontal Res 36: 244\u2013251","journal-title":"J Periodontal Res"},{"key":"670_CR35","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90: 1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"key":"670_CR36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0030-4220(93)90433-5","volume":"75","author":"Peters","year":"1993","unstructured":"Peters E, Lovas GL, Wysocki GP (1993) Lingual mandibular sequestration and ulceration. Oral Surg Oral Med Oral Pathol 75: 739\u2013743","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"670_CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","volume":"182","author":"Purcell","year":"2005","unstructured":"Purcell PM, Boyd IW (2005) Bisphosphonates and osteonecrosis of the jaw. Med J Aust 182: 417\u2013418","journal-title":"Med J Aust"},{"key":"670_CR38","unstructured":"Ramaswamy B, Shapiro CL (2003) Bisphosphonates in the prevention and treatment of bone metastases. Oncology (Williston Park) 17: 1261\u20131270"},{"key":"670_CR39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62: 527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"670_CR40","first-page":"679","volume":"56","author":"R","year":"2005","unstructured":"R\u00fchlmann D, K\u00fcbler AC (2005) Kieferosteomyelitis nach Therapie systemischer osteolytischer Prozesse mit Bisphosphonaten. Quintessenz 56: 679\u2013682","journal-title":"Quintessenz"},{"key":"670_CR41","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/annonc\/mdi206","volume":"16","author":"Sanna","year":"2005","unstructured":"Sanna G, Zampino MG, Pelosi G, Nole F, Goldhirsch A (2005) Jaw avascular bone necrosis associated with long-term use of bisphosphonates. Ann Oncol 16: 1207\u20131208","journal-title":"Ann Oncol"},{"key":"670_CR42","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/annonc\/mdg401","volume":"14","author":"Santini","year":"2003","unstructured":"Santini D, Vespasiani Gentilucci U, Vincenzi B et al. (2003) The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 14: 1468\u20131476","journal-title":"Ann Oncol"},{"key":"670_CR43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10006-005-0616-6","volume":"9","author":"Schirmer","year":"2005","unstructured":"Schirmer I, Peters H, Reichart PA, Durkop H (2005) Bisphosphonate und Osteonekrosen im Kieferbereich. Mund Kiefer GesichtsChir 9: 239\u2013245","journal-title":"Mund Kiefer GesichtsChir"},{"key":"670_CR44","unstructured":"Schwabe U, Ziegler R (2004) Mineralstoffpr\u00e4parate und Osteoporosemittel. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungsreport 2004. Springer, Berlin Heidelberg New York, S\u00a0697\u2013710"},{"key":"670_CR45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hed.2890040313","volume":"4","author":"Schwartz","year":"1982","unstructured":"Schwartz HC (1982) Osteonecrosis of the jaws: a complication of cancer chemotherapy. Head Neck Surg 4: 251\u2013253","journal-title":"Head Neck Surg"},{"key":"670_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0501.2001.012002109.x","volume":"12","author":"Shibutani","year":"2001","unstructured":"Shibutani T, Inuduka A, Horiki I, Luan Q, Iwayama Y (2001) Bisphosphonate inhibits alveolar bone resorption in experimentally-induced peri-implantitis in dogs. Clin Oral Implants Res 12: 109\u2013114","journal-title":"Clin Oral Implants Res"},{"key":"670_CR47","first-page":"536","volume":"144","author":"Shlomi","year":"2005","unstructured":"Shlomi B, Levy Y, Kleinman S, Better H, Kahn A, Shtabsky A, Chaushu G (2005) [Avascular necrosis of the jaw bone after bisphosphonate therapy]. Harefuah 144: 536\u2013539","journal-title":"Harefuah"},{"key":"670_CR48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.14219\/jada.archive.1978.0304","volume":"97","author":"Sonis","year":"1978","unstructured":"Sonis ST, Sonis AL, Lieberman A (1978) Oral complications in patients receiving treatment for malignancies other than of the head and neck. J Am Dent Assoc 97: 468\u2013472","journal-title":"J Am Dent Assoc"},{"key":"670_CR49","first-page":"210","volume":"28","author":"T","year":"2005","unstructured":"T\u00e4nzer J, Wilde F, Liese J, Niederwieser D, Al-Ali HA (2005) Osteonecrosis of the jaw bone in connection with the application of bisphosphonates. Onkologie 28: 210","journal-title":"Onkologie"},{"key":"670_CR50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.joms.2003.09.001","volume":"61","author":"Tarassoff","year":"2003","unstructured":"Tarassoff P, Csermak K (2003) Avascular necrosis of the jaws: risk factors in metastatic cancer patients. J Oral Maxillofac Surg 61: 1238\u20131239","journal-title":"J Oral Maxillofac Surg"},{"key":"670_CR51","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2005.05382.x","volume":"128","author":"Vannucchi","year":"2005","unstructured":"Vannucchi AM, Ficarra G, Antonioli E, Bosi A (2005) Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 128: 738","journal-title":"Br J Haematol"},{"key":"670_CR52","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","volume":"61","author":"Wang","year":"2003","unstructured":"Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104\u20131107","journal-title":"J Oral Maxillofac Surg"},{"key":"670_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01937197","volume":"Anat","author":"Wegner","year":"1872","unstructured":"Wegner G (1872) Der Einfluss des Phosphors auf den Organismus. Arch Path Anat (Virchows Arch) 55: 11\u201344","journal-title":"Arch Path"},{"key":"670_CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ar.1091770103","volume":"177","author":"Whalen","year":"1973","unstructured":"Whalen JP, O\u2019Donohue N, Krook L, Nunez EA (1973) Pathogenesis of abnormal remodeling of bones: effects of yellow phosphorus in the growing rat. Anat Rec 177: 15\u201322","journal-title":"Anat Rec"},{"key":"670_CR55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"Whyte","year":"2003","unstructured":"Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349: 457\u2013463","journal-title":"N Engl J Med"},{"key":"670_CR56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1615\/CritRevEukaryotGeneExpr.v13.i24.140","volume":"13","author":"Zalavras","year":"2003","unstructured":"Zalavras C, Shah S, Birnbaum MJ, Frenkel B (2003) Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Crit Rev Eukaryot Gene Expr 13: 221\u2013235","journal-title":"Crit Rev Eukaryot Gene Expr"}],"container-title":["Mund-, Kiefer- und Gesichtschirurgie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-005-0670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10006-005-0670-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-005-0670-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T15:54:01Z","timestamp":1736265241000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10006-005-0670-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s10006-005-0670-0","relation":{},"ISSN":["1432-9417","1434-3940"],"issn-type":[{"value":"1432-9417","type":"print"},{"value":"1434-3940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,3]]}}}